Researchers assessed whether plasma copeptin, a surrogate marker of vasopressin, is associated with lower-extremity amputation in diabetes.
Risk for dying from heart attack, stroke twofold higher among those with high BP, diabetes and short sleep
Farxiga has been approved to reduce the risk of hospitalization for heart failure in adults with type 2 diabetes mellitus and established cardiovascular disease (CVD) or multiple cardiovascular (CV) risk factors.
The risk for hospitalization with pandemic influenza is higher for patients with type 2 diabetes than for those without type 2 diabetes.
Poor glycemic control is associated with increased risks for stroke and death among patients with type 2 diabetes.
A larger percentage of weight loss regained after an intensive lifestyle intervention was positively associated with certain cardiometabolic risk factors in type 2 diabetes.
A class of diabetes drugs, called sodium-glucose co-transporter-2 inhibitors, protect against kidney disease in patients with type 2 diabetes.
In a study, elevated FGF23 was associated with increased risks of major adverse cardiovascular events and mortality in type 2 diabetes patients with normal or mildly impaired kidney function.
A novel machine learning-derived risk score can predict the risk for heart failure among outpatients with type 2 diabetes.
People who increase their consumption of sweet beverages — either fruit juice or drinks with added sugars — are at greater risk over time for developing diabetes.